Heart, Diabetes, Cancer Drugs on List for Medicare Price Negotiations, White House Says
TUESDAY, Aug. 29, 2023 (HealthDay News) — The Biden administration on Tuesday named the first 10 medicines that will be subject to price negotiations between Medicare and participating drug companies. The list represents the first step in a landmark program aimed at reducing the government’s drug spending, and potentially U.S.Continue Reading